Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
Sponsor: ARS Pharmaceuticals, Inc.
Summary
The study is to assess the safety of neffy or IM Adrenalin in patients who are experiencing allergic reactions after an OFC, allergen Immunotherapy (AIT), or other allergy challenge that may require epinephrine intervention.
Official title: A Phase IV Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
Key Details
Gender
All
Age Range
4 Years - Any
Study Type
INTERVENTIONAL
Enrollment
600
Start Date
2025-05-20
Completion Date
2027-06
Last Updated
2026-04-09
Healthy Volunteers
No
Conditions
Interventions
Neffy
Epinephrine nasal spray
Adrenaline
Epinephrine injection
Locations (6)
Orso Health, Inc.
La Jolla, California, United States
Children's National Hospital
Washington D.C., District of Columbia, United States
Endeavor Health
Glenview, Illinois, United States
University Of Michigan
Ann Arbor, Michigan, United States
Weill Cornell Medicine/NewYork Presbyterian Hospital
New York, New York, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States